Web-based preventive group intervention for persons bereaved by suicide: A randomized control group trial

Not Applicable

• Conditions: suicidalitybereavement, grief

• Registration Number: DRKS00014426
• Lead Sponsor: Medical School Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-04-12
• Study Completion: 2021-06-02
• Results First Posted: 2022-05-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 159

Inclusion Criteria

experienced loss of the suicide of a close person
- Men and women
- Adults between 18 and 75 years
- Access to the Internet
- German language skills
- signed consent form
- Currently not in psychotherapy

Exclusion Criteria

1) Acute Suicidality: Suicidality is assessed in the telephone interview using the Suicide Risk Assessment Interview (SRAI; Arnoldi, Van de Ven, Schrieken, & Lange, 2000; Knaevelsrud, 2005). If potential participants express acute suicidality, they will be excluded from the treatment. In addition, the suicide item of the Beck-Depression-Inventaroy (BDI-II; Hautzinger et al., 2006) is considered separately in the weekly after-session-measurements. The answer options of the item are: 1) I do not think about doing anything to me; 2) I sometimes think of suicide but would not do it; 3) I would like to kill myself; 4) I would kill myself if I had the opportunity. If participants indicate any other option than option 1), a telephone appointment will be arranged and a separate suicide screening will be conducted, which will check the concreteness and quality of the suicidal thoughts.

2) Increased Depressiveness: Participants who have a BDI-II score of > 35 are excluded from the treatment.

3) Psychotic Experience: Participants with a cut-off score > 13 in the Dutch Screening Device for Psychotic Disorder (SDPD; Knaevelsrud, 2005; Lange, Schrieken, Blankers, Van de Ven, & Slot, 2000) are excluded from the study.

4) Increased Alcohol, Drug, or Substance Use: Measured by the biographical questionnaire and the Structured Clinical Interview for DSM-IV Achse I (SKID-I; Wittchen, Zaudig, & Fydrich, 1997).

5) Persons already in psychotherapeutic treatment: Measured using the biographical questionnaire.

6) Borderline personality disorder and/or self-injurious behavior: Measured by the Structured Clinical Interview for DSM-IV Axis II (SKID-II; Wittchen et al., 1997)

7) Bipolar disorder: Measured by the SKID-I.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We expect a significant reduction in suicidality immediately after completion of the treatment, as well as three or six months later.<br>The questionnaire is provided in an online survey.<br><br>Measurements to assess suicidality:<br>- Revised Aquired Capability of Suicide Scale (ACSS-FAD, Spangenberg et al., 2014)<br>- Beck Depression Inventory (BDI-II, Hautzinger et al., 2006)<br>- Beck Scale for Suicide Ideation (Beck, Steer, & Ranieri, 1988)<br>- Revised Aquired Capability of Suicide Scale (ACSS-FAD, Spangenberg et al., 2016)